Investor Abingworth LLP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Abingworth LLP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2022-08-11 13D/A VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 21,064,222 21,313,822
2022-07-11 13D/A SRRA / Sierra Oncology Inc 2,193,626 0
2022-05-13 13G HLVX / HilleVax, Inc. 1,838,486
2022-04-08 13D/A SLNO / Soleno Therapeutics, Inc. 10,544,399 18,368,373
2022-04-07 13D/A VERA / Vera Therapeutics, Inc. 2,960,231 2,970,156
2022-03-21 13D/A SRRA / Sierra Oncology Inc 2,193,626 2,193,626
2022-02-25 13D/A XCUR / Exicure, Inc. 6,253,615 7,084,297
2022-02-14 13G/A PCVX / Vaxcyte, Inc. 4,168,718 4,183,716
2022-02-10 13D/A SRRA / Sierra Oncology Inc 2,043,626 2,193,626
2021-11-05 13D/A SRRA / Sierra Oncology Inc 2,035,752 2,043,626
2021-10-04 13D / JASPER THERAPEUTICS INC 5,628,558
2021-09-03 13D EFTR / eFFECTOR Therapeutics, Inc. 4,822,114
2021-05-24 13D VERA / Vera Therapeutics, Inc. 2,960,231
2021-04-20 13D RPHM / Reneo Pharmaceuticals, Inc. 1,858,226
2021-03-16 13D/A ACET / Adicet Bio, Inc. 1,640,721 1,615,385
2021-03-08 13D ACET / Adicet Bio, Inc. 1,640,721
2021-03-08 13G ACET / Adicet Bio, Inc. 1,640,721
2021-02-16 13G/A PSNL / Personalis, Inc. 4,462,452 0
2021-02-16 13G PCVX / Vaxcyte, Inc. 4,168,718
2020-10-16 13D SPRB / Spruce Biosciences, Inc. 1,792,518
2020-09-28 13D NCNA / NuCana plc - Depositary Receipt (Common Stock) 3,333,333
2020-08-20 13G/A PSNL / Personalis, Inc. 5,449,294 4,462,452
2020-07-31 13D/A VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 8,619,774 21,064,222
2020-07-06 13D/A SLNO / Soleno Therapeutics, Inc. 4,903,568 10,544,399
2020-02-14 13G PSNL / Personalis, Inc. 5,449,294
2020-02-14 13G/A US16706W1027 / Chiasma Inc 2,600,741 890,817
2020-02-10 13D SRRA / Sierra Oncology Inc 2,035,752
2020-01-17 13D/A TARA / Protara Therapeutics, Inc. 113,920
2019-11-14 13D/A TARA / Protara Therapeutics, Inc. 2,044,536 2,236,350
2019-08-09 13D XCUR / Exicure, Inc. 6,253,615
2019-06-17 13D/A SIEN / Sientra, Inc. 2,519,077 2,435,542
2018-12-27 13D SLNO / Soleno Therapeutics, Inc. 4,903,568
2018-05-09 13D/A SIEN / Sientra, Inc. 2,519,077
2018-02-14 13G/A PRTK / Paratek Pharmaceuticals Inc. 1,301,413 1,041,131
2018-02-14 13G/A CBAY / CymaBay Therapeutics, Inc. 1,600,000 1,147,077
2018-01-16 13D/A CRSP / CRISPR Therapeutics AG 2,158,017 1,897,618
2017-08-14 13D/A CRSP / CRISPR Therapeutics AG 2,604,314 2,158,017
2017-06-27 13D/A TARA / Protara Therapeutics, Inc. 2,044,536
2017-05-08 13D VRNA / Verona Pharma plc - Depositary Receipt (Common Stock) 8,619,774
2017-05-08 13D VNAPF / Verona Pharma Plc 8,619,774
2017-01-23 13D/A EVAR / Lombard Medical, Inc. 3,473,452
2016-11-22 13D/A DRNA / Dicerna Pharmaceuticals Inc 988,565 810,729
2016-11-03 13D CRSP / CRISPR Therapeutics AG 2,604,314
2016-04-20 13G CBAY / CymaBay Therapeutics, Inc. 1,600,000
2016-02-16 13G US16706W1027 / Chiasma Inc 2,600,741
2016-02-16 13G/A PRTK / Paratek Pharmaceuticals Inc. 1,301,413
2015-04-03 13D/A DRNA / Dicerna Pharmaceuticals Inc 988,565
2015-02-06 13G PRTK / Paratek Pharmaceuticals Inc. 1,310,482
2014-11-07 13D SIEN / Sientra, Inc. 2,199,012
2014-10-31 13D TARA / Protara Therapeutics, Inc. 2,017,872
2014-10-01 13D/A EVAR / Lombard Medical, Inc. 3,352,544
2014-08-25 13D/A EVAR / Lombard Medical, Inc. 3,115,957
2014-05-09 13D EVAR / Lombard Medical, Inc. 2,723,452
2014-02-14 13D DRNA / Dicerna Pharmaceuticals Inc 1,198,027
2014-02-14 13G/A CLVS / Clovis Oncology Inc 0
2014-02-14 13G RNA / Avidity Biosciences, Inc. 6,213,924
2013-07-22 13D/A AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) 8,195,169
2013-02-11 13G/A CLVS / Clovis Oncology Inc 1,437,884
2013-02-11 13G/A ACHV / Achieve Life Sciences, Inc. 603,740
2012-07-30 13D/A AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) 8,171,169
2012-06-06 13D/A AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) 10,147,168
2012-04-27 13D/A AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) 10,147,168
2012-04-16 13D/A AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) 14,155,509
2012-02-07 13G/A CALP / Caliper Life Sciences Inc
2012-02-07 13G/A ACHV / Achieve Life Sciences, Inc. 603,740